Published on 24th June 2014
Shire boss Flemming Ornskov on Monday admitted a higher offer from its US rival AbbVie could result in a takeover of the Irish drugmaker as he fleshed out his ambitions to double annual sales by 2020. Mr Ornskov, who has led Shire for just over a year, said he would not stand in the way of a potential transaction if the board believed it would deliver shareholder value. "Look at my track record. I’m all about shareholder return and value," he said when asked whether he would oppose a higher offer for the company. – The Daily Telegraph